Open this publication in new window or tab >>2024 (English)In: International Journal of Colorectal Disease, ISSN 0179-1958, E-ISSN 1432-1262, Vol. 39, article id 35Article in journal (Refereed) Published
Abstract [en]
Purpose Rectal cancer and its treatment have a negative impact on health-related quality of life (HRQoL). If risk factors for sustained low HRQoL could be identified early, ideally before the start of treatment, individualised interventions could be identified and implemented to maintain or improve HRQoL. The study aimed to develop a multivariable prediction model for global HRQoL 12 months after rectal cancer treatment.
Methods Within COLOR II, a randomised, multicentre, international trial of laparoscopic and open surgery for rectal cancer, a sub-study on HRQoL included 385 patients in 12 hospitals and five countries. The HRQoL study was optional for hospitals in the COLOR II trial. EORTC QLQ-C30 and EORTC QLQ-CR38 were analysed preoperatively and at 1 and 12 months postoperatively. In exploratory analyses, correlations between age, sex, fatigue, pain, ASA classification, complications, and symptoms after surgery to HRQoL were studied. Bivariate initial analyses were followed by multivariate regression models.
Results Patient characteristics and clinical factors explained 4–10% of the variation in global HRQoL. The patient-reported outcomes from EORTC QLQ-C30 explained 55–65% of the variation in global HRQoL. The predominant predictors were fatigue and pain, which significantly impacted global HRQoL at all time points measured.
Conclusion We found that fatigue and pain were two significant factors associated with posttreatment global HRQoL in patients treated for rectal cancer T1-T3 Nx. Interventions to reduce fatigue and pain could enhance global HRQoL after rectal cancer treatment.
Place, publisher, year, edition, pages
Springer Nature, 2024
Keywords
Colorectal cancer, Quality of life, Risk factors, EORTC QLQ, Fatigue, Pain
National Category
Surgery Urology and Nephrology Cancer and Oncology
Research subject
Research on Citizen Centered Health, University of Skövde (Reacch US)
Identifiers
urn:nbn:se:his:diva-23646 (URN)10.1007/s00384-024-04605-y (DOI)001175078400001 ()38441657 (PubMedID)2-s2.0-85186581865 (Scopus ID)
Funder
Swedish Cancer Society, CAN 2010/593CAN 2013/497Swedish Cancer Society, CAN 2016/362Swedish Cancer Society, Pj19 0303Anna-Lisa and Bror Björnsson FoundationStiftelsen Assar Gabrielssons fond
Note
CC BY 4.0 DEED
Eva Haglind eva.haglind@vgregion.se
This trial is registered with ClinicalTrials.gov No. NCT00297791
Open access funding provided by University of Gothenburg. The study received financial support from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-138751; ALFGBG-4307771; ALFGBG-718221; ALFGBG-965245), the Swedish Cancer Society (CAN 2010/593CAN 2013/497; CAN 2016/362; Pj19 0303), the Alice Swenson Foundation, Anna-Lisa and Bror Björnsson Foundation, Axel Linders Foundation, Assar Gabrielsson Foundation, and the Gothenburg Medical Society.
2024-03-052024-03-052024-04-15Bibliographically approved